Sartorius Stedim Biotech S.A. (SRTOY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Aubagne, France. Le PDG actuel est Rene Faber.
SRTOY a date d'introduction en bourse 2022-02-09, 9,961 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $214.01B.
Sartorius Stedim Biotech S.A. is a global supplier of instruments, consumables, and services for the biopharmaceutical industry. The company provides a comprehensive portfolio including cell lines, culture media, bioreactors, filtration and purification systems, and single-use bioprocess equipment, as well as data analytics software for optimizing biopharmaceutical development and production. It serves pharmaceutical manufacturers, research laboratories, and producers in the food and chemical industries with solutions spanning cell cultivation, fermentation, purification, and product storage and transportation. Founded in 1870 and headquartered in Aubagne, France, Sartorius Stedim Biotech operates as a subsidiary of Sartorius AG.
